OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-11 Cr | ₹-8.73 Cr | ₹1.66 Cr | ₹1.46 Cr | ₹1.34 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-11 Cr |
Mar2024 | ₹-8.73 Cr |
Mar2023 | ₹1.66 Cr |
Mar2022 | ₹1.46 Cr |
Mar2021 | ₹1.34 Cr |
How is Deferred Tax Assets / Liabilities of OXYGENTA PHARMACEUTICAL Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-11 Cr | Negative | |
Mar2024 | ₹-8.73 Cr | Negative | |
Mar2023 | ₹1.66 Cr | 13.55 | |
Mar2022 | ₹1.46 Cr | 9.03 | |
Mar2021 | ₹1.34 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹232.4 Cr | 17% | -5.3% | -29.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,218.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,158.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹126,710.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,586.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,496.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | 17% |
-5.3% |
-29.6% |
SENSEX | 1.6% |
2.1% |
2.6% |
You may also like the below Video Courses